Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo‐controlled study (IRON‐CLAD)

Erythropoiesis‐stimulating agents (ESA) are effective for chemotherapy‐induced anemia (CIA) but associated with serious adverse events. Safer alternatives would be beneficial in this population. The efficacy and safety of ferric carboxymaltose (FCM) as monotherapy for CIA was evaluated. This Phase 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Makharadze, Tamta, Boccia, Ralph, Krupa, Anna, Blackman, Nicole, Henry, David H., Gilreath, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298873/
https://www.ncbi.nlm.nih.gov/pubmed/34653287
http://dx.doi.org/10.1002/ajh.26376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298873/
https://www.ncbi.nlm.nih.gov/pubmed/34653287
http://dx.doi.org/10.1002/ajh.26376

Ejemplares similares